Seattle, WA, United States of America

Leif R Sloan

USPTO Granted Patents = 14 

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 596(Granted Patents)


Company Filing History:


Years Active: 2009-2023

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations of Leif R Sloan in Neural Stimulation Technology

Introduction

Leif R Sloan is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of neural stimulation technology. With a total of 14 patents to his name, he has been at the forefront of developing systems and methods that enhance the efficiency and efficacy of neural stimulation.

Latest Patents

One of his latest patents focuses on systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy. This invention discloses a system that applies electromagnetic stimulation to a patient's nervous system over two distinct time domains, utilizing different sets of stimulation parameters. The stimulation can be applied in various manners, including subthreshold, threshold, and suprathreshold levels, and can vary in duty cycle, amplitude, pulse repetition frequency, and other parameters. The invention aims to provide reduced power consumption while ensuring adequate symptomatic relief, making it a significant advancement in the field.

Career Highlights

Throughout his career, Leif R Sloan has worked with notable companies such as Advanced Neuromodulation Systems, Inc. and Northstar Neuroscience, Inc. His work in these organizations has contributed to the development of innovative technologies that address complex neurological conditions.

Collaborations

Leif has collaborated with several professionals in his field, including Bradford Evan Gliner and Brad Fowler. These collaborations have further enriched his work and have led to advancements in neural stimulation technologies.

Conclusion

Leif R Sloan's innovative work in neural stimulation technology has made a significant impact on the field. His patents and collaborations reflect his dedication to enhancing the efficacy of treatments for neurological conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…